§ Funding Round
Series B funding round for Ampersand Biomedicines raising $65M in March 2025
Series B funding round for Ampersand Biomedicines raising $65M in March 2025
| Investor | Firm Type | Partner |
|---|---|---|
Flagship Pioneering | — | — |
jason gardnerLEAD | Angel | jason gardner |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$165M
Top Valuation
-
Ampersand Biomedicines raised $65M in a Series B round.
The round was announced on 03/01/25.
The round was led by jason gardner.
